Jump Main Menu. Go directly to the main content

Sección de idiomas


Fin de la sección de idiomas

Access / Registration

Sección de utilidades

Fin de la sección de utilidades

Secondary menu End of secondary menu

Research projects

Start of main content

Synthetic nanoparticles as an innovative treatment for sepsis (SPRINT-4-SEPSIS)

19th national competition for scientific and technical research

Sepsis: Early Warning, Prevention and Treatment

Senior Researcher : Antonio Artigas Raventós


 Sepsis is a complex syndrome produced by a systemic infection that is accompanied by a dysregulated host immune response, causing, in many cases, an acute respiratory distress syndrome (ARDS) associated with a mortality rate of 40%. Despite decades of research, there is still a lack of a specific treatment. It is well established that the administration of mesenchymal stromal cells (MSC) has a remarkable therapeutic effectiveness and that its paracrine activity, mediated by the secretion of exosomes, has a crucial role on MSCs’ action.
In our approximation, we aim at devising a free-cell therapeutic strategy based on the production of synthetic nanovesicles carrying specific proteins and miRNAs from MSC-derived exosomes cargo that will down-regulate inflammation, will assist the restoration of systemic immune homeostasis and improve the lung injury in a sepsis model.
During the second year of the project we have demonstrated that pre-stimulating MSC with LPS (mimicking a septic environment) enhances their paracrine activity by increasing the amount of secreted exosomes. In addition, through a scrach assay, we observed that the treatment of epithelial cells with exosomes derived from pre-stimulated MSC (LPS exosomes) increases a 10% its capacity to proliferate and to regenerate the wound healing in comparison with the epithelial cells treated with exosomes derived from non pre-stimulated MSC. We also observed that both LPS and control exosomes were able to decrease the expression of pro-inflammatory cytokines by pre-activated macrophages at the same level. This results were confirmed by an analysis of the protein content of both types of exosomes. This revealed that pre-conditioning MSCs to a septic environment modifies the protein cargo of its exosomes, resulting in the appearance proteins related to cell cycle regulation, cell proliferation and proteins with a key role on suppressing hyperinflammation.
We have rised a promising first step towards a cell-free therapeutic strategy for sepsis, demonstrating the potential regenerative and anti-inflamatory effect of MSC-derived exosomes and by studying the specific components in charge of this therapeutic activity. 


Scientific Production
Magazine Articles -
Communications at national conferences 1
Communications at international conferences -


  • Activities related
  • Projects related
  • News related
  • Publications related

see all

End of main content